Frank H.

Executive Director, Global Safety Strategy Lead

San Francisco Bay Area

About

Experienced Physician / Leader skilled in Drug Safety, Pharmacovigilance and Risk Management. Epidemiology training from Johns Hopkins University. Executive MBA from Wharton Business School, University of Pennsylvania

Experience

  • Executive Director, Global Patient Safety at Gilead Sciences
    Jan 2020 - Present · 6 yrs 7 mos

  • Senior Global Program Safety Lead at Novartis
    Dec 2008 - Jan 2020 · 11 yrs 2 mos

    Neuroscience, Oncology

  • Executive Director, Head of Drug Safety at AMAG Pharmaceuticals
    Dec 2007 - Dec 2008 · 1 yr 1 mo

  • Senior Director, Clinical Risk Management at Merck
    Jun 2006 - Dec 2007 · 1 yr 7 mos

    Oncology, Immunology

  • Vice President, Head of Pharmacovigilance at Allergan
    2002 - 2006 · 4 yrs

    Senior Management, Neuroscience, Ophthalmology, Dermatology